Synthetic glucocorticoids (GCs), such as dexamethasone (Dex), are clinically prescribed to pregnant women at risk of preterm delivery or bearing fetuses at risk of congenital adrenal hyperplasia. Prenatal Dex administration was associated with several neuropsychological and behavioural disorders during infancy and adulthood. The long-lasting impact of prenatal GCs on fetal brain development is well known; however, the mechanisms through which prenatal GCs induce these long-lasting disturbances have not been discovered yet. Recently, prenatal GC exposure was found to induce fetal brain growth restriction and changed the expression of one of the genes that are involved in neural cell death, survival, and differentiation programmes: p73. The p73 gene encodes for 2 protein variants; the pro-apoptotic protein (TAp73), and the anti-apoptotic protein (ΔNp73). It is not clear how synthetic GCs modulate this gene and which neural brain cell types (neurons or glia) are affected. In this study, the impact of prenatal Dex on fetal brain development will be discovered by detecting the expression and the neural location of p73 gene/protein variants. Pregnant dams received daily intraperitoneal injections of either Introduction and Objectives: Vitamin D deficiency is associated with several complex disorders including multiple sclerosis (MS). Several factors influence vitamin D levels and its optimal multifunction maintenance. Our objective was to assess quantifiable variables influencing vitamin D level and metabolism in MS patients from Kuwait. Methods: This is a case-control study involving 50 Kuwaiti MS patients and 50 healthy control Kuwaiti individuals recruited at Dasman Diabetes Institute's neurology clinic. Plasma vitamin D levels were determined using an enzymelinked immunosorbent assay. Vitamin D receptor (VDR) variants were assessed using Taqman genotyping assays. Skin pigmentation indices were ascertained using a hand-held spectrophotometer. Statistical analyses included Mann-Whitney rank sum test, χ 2 test, and Student t test. A p value <0.05 was considered significant for all tests. Results: We found overall vitamin D levels to be deficient in both groups, and supplement use to be common practice. VDR variants Taq-I (rs731236) GG genotype and Bsm-I (rs1544410) CC genotype were associated with MS risk (p = 0.0008, p = 0.003; respectively). VDR SNP Apa-I (rs7975232) AA genotype was associated with low disease progression (p = 0.003). VDR variant Fok-I (rs2228570) GG genotype was associated with higher constitutive melanin indices in both cohorts (p = 0.04). Conclusions: Several quantifiable variables related to vitamin D are associated
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Dr Activation of microglia/macrophages following cerebral ischemia may be beneficial or detrimental for the survival of brain cells. This ambiguity was explained by findings that ischemia induces transformation of the microglia/macrophages into two different phenotypes, a process often referred to as polarization into M1 and M2 phenotypes. To which extent these processes depend on paracrine signaling from other cells of the neurovascular unit (NVU) is not clear. The aim of this in vitro study was to explore whether polarization of these cells into the two phenotypes could occur in the absence/low abundance of other NVU cells and to assess the effect of microglia/macrophage-derived cytokines on astrocytes' viability during anoxia. Primary cultures of rat microglia/macrophages were exposed to 2 h of oxygen glucose deprivation (OGD) and then incubated further under normal conditions, which was considered as a recovery period. Expression of phenotype-specific markers at transcript and protein levels and secretion of phenotype-specific cytokines were explored at different time points of the recovery period by real-time PCR, immunohistochemistry and ELISA, respectively. The astrocytes' viability was explored in the presence or absence of phenotype-specific cytokines during anoxia or in control conditions. The OGD protocol has triggered an increase in expression/secretion of M2-specific markers/cytokines, with a similar time pattern as revealed after ischemia in vivo. Expression/secretion of M1-specific markers/cytokines did not show a common time pattern, but there was a general tendency for an increase during the recovery period. Well-known pharmacological protocols for the induction of the M1 and M2 phenotypes have caused secretion of cytokines that were consistent with polarization of these cells into M1 phenotype and polarization into mixed (M1 and M2) phenotypes, respectively. Surprisingly, all M1-specific and 2 out of the 3 tested M2-specific cytokines revealed protective effects on astrocytes during anoxia. Polarization of the brain microglia/macrophages into the M2 phenotype could be triggered by OGD in vitro, so it appeared that this process was largely independent from paracrine signaling of NVU cells. On the other hand, no clear polarization into the M1 phenotype after OGD or shift of the M2 into M1 phenotype, processes that were described after ischemia in vivo, could be confirmed in vitro, so it appeared that they depended to a greater extent on paracrine signaling from other NVU cells. Cytokines that were released from polarized microglia were protective for astrocytes during anoxia.
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Intrauterine Growth Restriction Is Associated with Changes in Placental Expression of Metastasis Tumor Antigens in Rats
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Molecular mechanisms underlying placental formation in normal and intrauterine growth restriction (IUGR) placentas are not clearly known. Since metastasis tumor antigen (MTA) 1 and MTA2 promote cell proliferation while MTA3 suppresses proliferation, we hypothesized that during normal placental development there would be an increase in MTA1 and MTA2 expression and a decrease in MTA3 expression, which might be reversed with IUGR. Pregnant Sprague-Dawley rats received daily intraperitoneal injections of either dexamethasone (0.4 mg/kg; DEX group), or saline (control group) starting from 14 days of gestation (dg) to either 19 or 21 dg. Gene and protein expression of MTA1, MTA2 and MTA3 in the basal and labyrinth zones of the placenta were investigated by real-time PCR, Western blotting and immunohistochemistry, respectively. The expression of the proliferating cell nuclear antigen and caspase-3 was investigated by immunohistochemistry to assess cell proliferation and apoptosis, respectively. The gene expression of MTA1 increased on 19 dg, and its cytoplasmic protein expression increased at 21 dg in the labyrinth zone in the DEX group. In the basal zone, an increase in its cytoplasmic expression was on 19 dg and a decrease in nuclear expression at 21 dg in the DEX group. The MTA2 gene expression decreased in the labyrinth zone at 19 and 21 dg in the DEX group. The MTA2 protein expression increased in the cytoplasm of the basal zone and in the labyrinth zone at 19 dg in the DEX group. The MTA3 gene expression decreased on 19 and 21 dg in the labyrinth zone of the DEX group and at 21 dg in the basal zone of the DEX group. In the basal zone its protein expression decreased in the nuclear fraction at 21 dg and increased in the cytosolic fraction at 19 dg in the DEX group. Cell proliferation showed a decrease and cell death showed an increase in the DEX group. IUGR is associated with molecular changes in MTA expression in different placental zones and cell fractions. This could be linked to decreased cell proliferation and increased cell death.
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